487 related articles for article (PubMed ID: 36259505)
1. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in ovarian cancer: Diagnosis and treatment.
Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
[TBL] [Abstract][Full Text] [Related]
3. New trends in diagnosing and treating ovarian cancer using nanotechnology.
Zhang J; Ding H; Zhang F; Xu Y; Liang W; Huang L
Front Bioeng Biotechnol; 2023; 11():1160985. PubMed ID: 37082219
[TBL] [Abstract][Full Text] [Related]
4. Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.
Bhardwaj BK; Thankachan S; Magesh P; Venkatesh T; Tsutsumi R; Suresh PS
Reprod Sci; 2023 Feb; 30(2):335-349. PubMed ID: 35585292
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation for Cancer Therapy.
Montané X; Bajek A; Roszkowski K; Montornés JM; Giamberini M; Roszkowski S; Kowalczyk O; Garcia-Valls R; Tylkowski B
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244513
[TBL] [Abstract][Full Text] [Related]
6. Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.
Rhoda K; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
Expert Opin Drug Deliv; 2015 Apr; 12(4):613-34. PubMed ID: 25300775
[TBL] [Abstract][Full Text] [Related]
7. Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.
Engelberth SA; Hempel N; Bergkvist M
Crit Rev Oncog; 2014; 19(3-4):281-315. PubMed ID: 25271436
[TBL] [Abstract][Full Text] [Related]
8. The new era of nanotechnology, an alternative to change cancer treatment.
Jurj A; Braicu C; Pop LA; Tomuleasa C; Gherman CD; Berindan-Neagoe I
Drug Des Devel Ther; 2017; 11():2871-2890. PubMed ID: 29033548
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
Kaur M; Nagpal M; Aggarwal G
Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
11. General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):311-318. PubMed ID: 28797169
[TBL] [Abstract][Full Text] [Related]
12. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in nanotechnology for cancer therapy.
Tang MF; Lei L; Guo SR; Huang WL
Chin J Cancer; 2010 Sep; 29(9):775-80. PubMed ID: 20800018
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple- Negative Breast Cancer (TNBC).
Kanugo A; Gautam RK; Kamal MA
Curr Pharm Biotechnol; 2022; 23(13):1581-1595. PubMed ID: 34967294
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy.
Li Y; Gao Y; Zhang X; Guo H; Gao H
Int J Pharm; 2020 Dec; 591():119986. PubMed ID: 33069895
[TBL] [Abstract][Full Text] [Related]
16. Nano-drug delivery system: a promising approach against breast cancer.
Malik JA; Ansari JA; Ahmed S; Khan A; Ahemad N; Anwar S
Ther Deliv; 2023 May; 14(5):357-381. PubMed ID: 37431741
[TBL] [Abstract][Full Text] [Related]
17. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
18. Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer.
Abujamous L; Soltani A; Al-Thawadi H; Agouni A
Biomol Biomed; 2024 Mar; 24(2):230-237. PubMed ID: 38231530
[TBL] [Abstract][Full Text] [Related]
19. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy.
Dey AD; Bigham A; Esmaeili Y; Ashrafizadeh M; Moghaddam FD; Tan SC; Yousefiasl S; Sharma S; Maleki A; Rabiee N; Kumar AP; Thakur VK; Orive G; Sharifi E; Kumar A; Makvandi P
Semin Cancer Biol; 2022 Nov; 86(Pt 2):396-419. PubMed ID: 35700939
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
